Q5117 Injection., kanjinti, 10 milligrams
Q-Codes
Also known as: Kanjinti injection, trastuzumab-anns
Injection of Kanjinti, trastuzumab-anns biosimilar per 10 milligrams, a HER2-antagonist antibody.
Clinical Context
Used for HER2-positive breast cancer and metastatic gastric cancer therapy.
RVU Breakdown
| Work RVU | 0.00 |
| Practice Expense RVU | 0.00 |
| Malpractice RVU | 0.00 |
| Total RVU | 0.00 |
Specialties
Track This Code in RVU Edge
Log procedures, calculate wRVUs, and benchmark against MGMA data — all in one app.
CPT® is a registered trademark of the American Medical Association. Data sourced from CMS Physician Fee Schedule RVU26A. Descriptions, synonyms, and clinical context are original content by RVU Edge.